Approximation of emicizumab plasma levels in emergency situations. A practical approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Approximation of emicizumab plasma levels in emergency situations. A practical approach

Published:2021-02 Issue:2 Volume:27 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Pekrul Isabell¹²^ORCID,Pfrepper Christian³^ORCID,Calatzis Geli²,Giebl Andreas⁴,Siegemund Annelie³,Grützner Stefanie⁴,Spannagl Michael²

Affiliation:

1. Department of Anaesthesiology Ludwig‐Maximilian‐University of Munich Munich Germany

2. Department of Transfusion Medicine, Cell Therapeutics and Haemostaseology Ludwig Maximilian‐University of Munich Munich Germany

3. Division of Haemostaseology Medical Department I University Hospital Leipzig Leipzig Germany

4. Institute for Transfusion Medicine and Hemostaseology Augsburg University Clinic Augsburg Germany

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14264

Reference19 articles.

1. Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

2. Emicizumab Prophylaxis in Hemophilia A with Inhibitors

3. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model

4. The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A

5. Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center;Pediatric Investigation;2024-07-22

2. Multicenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A;Journal of Thrombosis and Haemostasis;2024-07

3. Bispecific Antibody Detection Using Antigen-Conjugated Synthetic Nucleic Acid Strands;ACS Sensors;2023-10-19

4. Emicizumab assays evaluations with four different reagents in severe haemophilia A patients: Concentration from baseline to maintenance therapy;Haemophilia;2022-11-29

5. Real‐world data on emicizumab prophylaxis in the Milan cohort;Haemophilia;2022-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3